Vivozon Pharmaceutical

082800 · KOSDAQ · Health Care · SMALL CAP

Conversion price adjustment

(Conversion price adjustment)· FILED 2026-10-12· RCEPT 20261012900381

About this filing

The conversion or exercise price of outstanding share-linked bonds has been adjusted (typically lowered after a fall in the share price, under the bond's terms).

Why companies file it: A lower conversion price means more shares if the bonds are converted.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-10-12, Conversion price adjustment
SourceDART rcept 20261012900381 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-10-12 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).